Aromatase Inhibitors for the adjuvant treatment of breast cancer in postmenopausal women

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy, safety, and quality of life (QOL) data when available, of adjuvant third‐generation AIs (anastrozole, letrozole, exemestane) compared to tamoxifen or placebo in postmenopausal women with e...

Full description

Saved in:
Bibliographic Details
Published in:Cochrane database of systematic reviews 2017-05, Vol.2017 (5)
Main Authors: Ali, Asma, Kumar, Vikaash Naveen‐Chandra, Shah, Prakeshkumar S, Warner, Ellen, Beyene, Joseph, Dent, Rebecca, Simmons, Christine
Format: Article
Language:English
Subjects:
Medicine General & Introductory Medical Sciences
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the efficacy, safety, and quality of life (QOL) data when available, of adjuvant third‐generation AIs (anastrozole, letrozole, exemestane) compared to tamoxifen or placebo in postmenopausal women with early stage hormone receptor‐positive breast cancer.
ISSN:1469-493X
DOI:10.1002/14651858.CD011133.pub2